The following chart shows the massive potential in the Dutch pharmaceuticals and healthcare markets; a population of almost 17 million with high per…

Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by Schering Plough, the Netherlands…

In keeping with its reputation as a forerunner, the Dutch healthcare eco-system is currently reinventing itself to ensure it remains ahead of the game…

The Netherlands is clearly a fertile environment for its 2,200 life science and medtech companies. However, the Dutch ambition to be a frontrunner in…

Sobi is a leading integrated biopharmaceutical company dedicated to developing innovative therapies and services to improve the lives of rare disease…

In an exclusive interview, the Vice President of Philips Research explains the key to continuous evolution, improving healthcare stakeholder…

Healthcare is moving towards an increased level of personalization and active participation of the patient in the decision-making process. Roland van…

Teva Benelux and Nordics' GM lifts the lid on how the company has grown to become the market leader in the Netherlands. Looking at Teva’s…

Yvonne van Rooy, president of the NVZ, explains the patient's increasing role as a partner in Dutch healthcare and how greater investment in ICT…

DB Schenker's Bart Coenen (BC) and Vincent Coolen (VC) explain the company's Vision 2020 and talk about the benefits for pharma companies of…

Roeland Van Dam, CEO of Bilthoven Biologicals, a historical Dutch company which remains at the forefront of vaccine production, explains how being…

Han Brouwer, General Manager for Actelion in the Netherlands, explains how Opsumit’s successful market launch has strengthened Actelion’s…